Skip to main content

February 2026

IMTECH Recruitment for Tuberculosis Research - Pharmacy Candidates Eligible

CSIR-IMTECH recruitment 2026 : SRF, Project Associate posts for TB drug resistance research. MSc/MPharma/Engineering eligible. Last date 27 Feb.
Centre for Cellular and Molecular Biology (CSIR-CCMB) Recruitment for Life Sciences & Biotechnology Candidates
Masters degree in Life sciences/ biotechnology. CSIR-Centre for Cellular and Molecular Biology
BITS Hyderabad Research Fellowship for Biotechnology & Molecular Biology Candidates
M.Sc / M.Tech / M.E degree in Biotechnology or Molecular Biology. Candidates having NET qualifications will have an additional advantage.
CSMCRI Invites Applications from Life Sciences & Biotechnology Candidates
CSMCRI career for M.Sc., in Marine Biology / Marine Science / Biotechnology / Life Sciences
Interview for Freshers Biotech / Life Sciences in Production at Biological E
Practical exposure to large-scale vaccine manufacturing. Hands-on experience in GMP-compliant production environments.
Ipca Laboratories Walk-In Drive for Freshers | Production, QA & QC
Ipca Laboratories Ltd. has launched its Centre of Excellence - a specialized training initiative aimed at providing hands-on industrial exposure to students aspiring to build a career in the pharmaceutical industry.
Macleods Walk-In Interview for Production, QC & QA
Openings in Quality Control, Quality Assurance, OSD Production. Macleods ; Experience into QMS / IPQA / Process & Cleaning Validation.
Production Jobs at Fresenius Kabi India
Preference having exposure of regulatory inspections. Handling and controlling of daily production activities, improvement initiatives, interdepartmental coordination and manpower handling.
OneSource Speciality Pharma Hiring for DS Manufacturing, DP Manufacturing & QA Roles
B.Sc, B.Pharm, M.Sc, M.Pharm; Responsible for Operation of isolators and associated equipment related to cartridge, Vials and Pre-Filled syringes, PFS at OneSource Speciality Pharma
ICMR Study Shows Shorter Oral Regimens for Drug-Resistant TB Are Cost-Effective for India’s Health System

A recent study led by the Indian Council of Medical Research (ICMR) has found that shorter, all-oral treatment regimens for multidrug-resistant and rifampicin-resistant tuberculosis (MDR/RR-TB) could deliver better health outcomes at lower costs compared to longer traditional therapies in India.